Oscar Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on March 3, 2021, by Oscar Health, Inc., a Delaware corporation. The report covers corporate governance updates and the completion of the Company's initial public offering (IPO) on March 5, 2021.
Key Financial Metrics
The filing details the financial specifics of the IPO but does not provide operational metrics such as revenue, profit, cash flow, margins, or debt levels.
- Shares Sold by Company: 36,391,946 shares of Class A Common Stock.
- Shares Sold by Existing Stockholders: 649,080 shares of Class A Common Stock.
- Offering Price: $39.00 per share.
- Gross Proceeds to Company: $1,419,285,894 (before underwriting discounts, commissions, and offering expenses).
- Underwriter Option: 30-day option to purchase up to 5,556,153 additional shares.
Material Changes
The primary material change is the transition from a private to a public company via the IPO. Additionally, the Company filed an Amended and Restated Certificate of Incorporation and Bylaws effective March 3, 2021, which were approved prior to the IPO closing.
Guidance, Outlook, and Risks
This filing does not contain management guidance, future outlook, risk factors, or commentary on contingencies. It is a procedural report regarding the IPO execution and charter amendments.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and offering expenses.
- Confirm the exercise status of the underwriters' 30-day option to purchase additional shares.
- Review the full text of the Amended and Restated Certificate of Incorporation and Bylaws (Exhibits 3.1 and 3.2) for specific governance provisions.
- Check subsequent filings for the allocation of IPO proceeds and updated liquidity position.